Upregulation of ADAM-10 cleaves APP into non-amyloidogenic species (reviewed by Andrew et al., 2016) but it is unclear still how membrane-bound ADAM-10 interacts with intracellular tau and whether tau 153–441 has any physiologic relevance to AD (Quinn et al., 2018). The gene discussed is MAPT; the disease is Alzheimer disease.